Management of asthma in children

Area of Science:

• Pulmonology and Respiratory Medicine
• Clinical Immunology
• Pharmacology

Background:

• Chronic asthma management has evolved significantly, driven by a deeper understanding of its inflammatory basis.
• The National Heart, Lung, and Blood Institute's 1991 guidelines provide a framework for asthma care.
• Inflammation is now recognized as a central factor in asthma pathogenesis and treatment.

Purpose of the Study:

• To review recent changes in the management of chronic asthma.
• To highlight the role of inflammation in asthma.
• To outline current therapeutic strategies and non-pharmacologic interventions.

Main Methods:

• Review of current literature and clinical guidelines on asthma management.
• Analysis of therapeutic options based on asthma severity.
• Emphasis on the integration of pharmacologic and non-pharmacologic approaches.

Main Results:

• Beta agonists, cromolyn, and nedocromil remain primary treatments for mild to moderate asthma.
• Inhaled corticosteroids are crucial for managing moderate to severe asthma.
• Non-pharmacologic strategies, including allergen avoidance and patient education, are integral to comprehensive care.

Conclusions:

• Modern asthma management prioritizes controlling airway inflammation.
• A multi-faceted approach combining medication, allergen avoidance, and education improves patient outcomes.
• Guidelines continue to shape effective chronic asthma care strategies.